BME100 f2013:W1200 Group14 L2
From OpenWetWare
BME 100 Fall 2013  Home People Lab WriteUp 1  Lab WriteUp 2  Lab WriteUp 3 Lab WriteUp 4  Lab WriteUp 5  Lab WriteUp 6 Course Logistics For Instructors Photos Wiki Editing Help  
OUR TEAMLAB 2 WRITEUPDescriptive StatisticsExperiment 1: Human 0mg: Average: 3.834 Standard Deviation: 1.523010177 Endpoint # 10 Standard Error: 0.481618106 5mg: Average: 8.932 Standard Deviation: 1.593931547 Endpoint #: 10 Standard Error: 0.504045412 10mg: Average: 61.622 Standard Deviation: 30.11069386 Endpoint #: 10 Standard Error: 9.521837451 15mg: Average: 657.941 Standard Deviation: 212.9429762 Endpoint #: 10 Standard Error: 67.33848166 Experiment 2: RAT 0mg: Average Inflammotin Levels: 10.516 Standard Deviation: 2.225551617 Endpoint #: 5 Standard Error: 0.445110323 10 mg: Average Inflammotin Levels:11.112 Standard Deviation:7.402885924 Endpoint#:5 Standard Error: 1.480577185
[[]]==Results== (Please include welllabeled graphs of the results.)
AnalysisExperiment 1:People 0mg and 5 mg 8.59631E07 0mg and 10 mg 9.94377E06 0mg and 15 mg 1.39436E08 5 and 10 mg 3.01859E05 5 and 15 mg 1.57101E08 10mg and 15 mg 6.4824E08
Experiment 2:Rats
Summary/DiscussionThe higher doses of LPS, for example: 15mg, cause the protein inflammotin to increase in the blood stream of the humans by a factor of 171.6. The change in inflammotin levels from 10mg to 15mg was highly significant due to the increase of the LPS distributed. On experiment 1 on humans, the pvalues between all the different doses were significantly less than 0.05 so all the differences were significant. For experiment 2, with rats, the pvalue was 0.8674 so the difference in inflammotin levels was not significant. The lowest possible dose of LPS on humans is 5mg because the pvalue between 0mg and 5mg was less than 0.05. This makes the 5mg dosage significant.
